S5 Ep20: Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer
OncLive® On Air - Un pódcast de OncLive® On Air
Dr. Sherman discusses the incidence of RET fusions in medullary thyroid cancer and the current clinical landscape of RET inhibitors in the field.
